Vera Therapeutics, Inc. SEC filings VERA
Vera Therapeutics, Inc. has 476 filings in SEC EDGAR's recent list, going back to Feb 25, 2021. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 13, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2022 | — |
| CORRESP | Letter to the SEC | Jun 9, 2022 | — |
| EFFECT | Filing | Feb 9, 2022 | — |
| CORRESP | Letter to the SEC | Feb 7, 2022 | — |
| CORRESP | Letter to the SEC | Feb 7, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2022 | — |
| DRS | Filing | Jan 4, 2022 | — |
| EFFECT | Filing | May 13, 2021 | — |
| SEC STAFF LETTER | Filing | May 13, 2021 | — |
| CERT | Filing | May 13, 2021 | — |
| CORRESP | Letter to the SEC | May 12, 2021 | — |
| CORRESP | Letter to the SEC | May 12, 2021 | — |
| CORRESP | Letter to the SEC | May 12, 2021 | — |
| 8-A12B | Filing | May 11, 2021 | — |
| UPLOAD | Letter from the SEC | May 10, 2021 | — |
| CORRESP | Letter to the SEC | May 10, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2021 | — |
| CORRESP | Letter to the SEC | Apr 23, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 15, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2021 | — |
| DRS | Filing | Mar 19, 2021 | — |
| D | Filing | Feb 25, 2021 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1831828
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.